The Charcot-Marie-Tooth Association (CMTA) aims to cast attention on the most commonly inherited peripheral neuropathy in the world and educate not only those who have CMT, but also the tens of thousands of people who provide support and care for the CMT community. The CMTA's STAR™ Initiative is accelerated, groundbreaking research, which is on the verge of providing new and better treatments to patients, and ultimately a cure. For the first time, our vision for a world without CMT is tantalizingly close.
